抗青光眼术后眼压不降的再手术治疗

来源 :实用医学杂志 | 被引量 : 0次 | 上传用户:gxx0103
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 :评价房水引流管植入术对抗青光眼术后眼压不降的治疗效果 ,探讨其并发症及预防。方法 :对 30例抗青光眼手术术后眼压不降的患者施行房水引流管植入术 ,术后随访 3~ 36个月。结果 :眼压由术前 3 5 0~ 8 34(5 5 7± 1 2 3)kPa下降至 0 40~ 3 5 8(2 36± 1 0 8)kPa ,手术成功率为 80 % (2 4/30 ) ,术后视力提高或保持不变 83% (2 5 /30 )。并发症包括前房出血、浅前房、脉络膜脱离、引流管内口堵塞、引流管外露。结论 :房水引流管植入术是抗青光眼术后眼压不降再手术的一种有效治疗方法 ,但存在一些并发症 ,应引起医生的重视。 OBJECTIVE: To evaluate the therapeutic effect of aqueous humor drainage tube implantation against glaucoma postoperative intraocular pressure (IOP), and to explore its complications and prevention. Methods: A total of 30 patients with intraocular pressure (IOP) after glaucoma surgery were treated with aqueous humor drainage. The patients were followed up for 3 to 36 months. Results: The intraocular pressure decreased from 35 to 8 34 (57 ± 123) kPa to 0 40 to 358 (2 36 ± 1 0 8) kPa preoperatively, and the success rate was 80% (2 4 / 30), postoperative visual acuity improved or remained unchanged 83% (25/30). Complications include anterior chamber bleeding, shallow anterior chamber, choroidal detachment, drainage tube plug, drainage tube exposed. Conclusion: Aqueous humor drainage tube implantation is an effective treatment for preventing intraocular pressure from recurrence after glaucoma surgery. However, there are some complications that should be paid more attention to by doctors.
其他文献
目的 :探讨癌基因MDM2 在食管鳞癌中的表达和意义。方法 :采用免疫组织化学链菌素亲生物素蛋白过氧化物酶连接法 (SP法 )检测MDM2 在食管鳞癌中的表达 ,将检测结果与临床资料
目的:评价胶原酶注射治疗腰椎间盘突出症的临床应用价值,介绍此技术的操作方法及适应证和禁忌证.方法:通过门诊复查、信件随访观察胶原酶化学溶盘术后的效果.结果:53例腰椎间